About Shilpa Medicare Ltd
Shilpa Medicare engaged in the manufacturing of API, Formulation and Development service.
Founded
1987
CEO
Omprakash Inani
Employees
1,241
HQ
Raichur, India
Finished Products
1Formulation
₹728.31Cr2Product developement
₹409.24Cr3Sales of products
₹178.11Cr4Trading Goods
₹54.00Cr5Power Sales
₹9.04Cr6Export incentives
₹0.17CrRaw Materials
1Raw Materials Consumed
₹270.02Cr2Others
₹100.23Cr3Bulk Drugs-Purchased
₹22.01Cr4Ibuprofen-Purchased
₹14.68Cr5Others - Purchases
₹12.75Cr6Tri Fluoro methane sulfulfonat
₹9.43Cr7Packing materials
₹0.10CrAbout Shilpa Medicare Ltd
Shilpa Medicare engaged in the manufacturing of API, Formulation and Development service.
Founded:1987
CEO:Omprakash Inani
Employees:1,241
HQ:Raichur, India
Finished Products
1Formulation
₹728.31Cr2Product developement
₹409.24Cr3Sales of products
₹178.11Cr4Trading Goods
₹54.00Cr5Power Sales
₹9.04Cr6Export incentives
₹0.17CrRaw Materials
1Raw Materials Consumed
₹270.02Cr2Others
₹100.23Cr3Bulk Drugs-Purchased
₹22.01Cr4Ibuprofen-Purchased
₹14.68Cr5Others - Purchases
₹12.75Cr6Tri Fluoro methane sulfulfonat
₹9.43Cr7Packing materials
₹0.10CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹952
52W Low
₹260
Volume1.47M
Avg VolumeN/A
Beta0.85
Dividend Yield0.06%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
61.07x
Valuation
P/B Ratio
7.01x
Valuation
EPS
₹15.20
Valuation
Dividend Yield
0.06%
Valuation
ROE
9.39%
Profitability
ROCE
10.73%
Profitability
Revenue by Segment
Contribution & growth by business line
Pharmaceutical product and services
+19.8%99.8%
₹1,536.29 Cr
Power
-15.5%0.1%
₹1.69 Cr
others
-46.4%0.1%
₹0.89 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
35.5%
International
64.5%
Within India35.5%
Europe28.8%
ROW25.4%
USA10.3%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.25x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
10.1%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.